✦ LIBER ✦

Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer’s disease: ADAS-cog subscale results from the Alphase study

✍ Scribed by D. Saumier; Anh Duong; D. Haine; D. Garceau; J. Sampalis

Book ID: 107669919
Publisher: Springer
Year: 2009
Tongue: English
Weight: 274 KB
Volume: 13
Category: Article
ISSN: 1279-7707
DOI: 10.1007/s12603-009-0217-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of tramiprosate in patients with

Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study

✍ S. Gauthier; P. S. Aisen; S. H. Ferris; D. Saumier; A. Duong; D. Haine; D. Garce 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 175 KB

Detecting treatment effects with combina

Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease

✍ Ralf Ihl; Steven Ferris; Philippe Robert; Bengt Winblad; Serge Gauthier; Frank T 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Abstract ## Objective When complex cognitive functions are measured with multi‐item scales like the Alzheimer's Disease Assessment Scale – cognitive subscale (ADAS‐cog), it seems valuable information can be lost due to combination of the ADAS‐cog items results into a total score. We hypothesize

The validity and reliability of the Turk

The validity and reliability of the Turkish versii̇on of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects

✍ H. Mavioglu; M. Gedizlioglu; S. Akyel; T. Aslaner; E. Eser 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## Objectives The cognitive subscale of the Alzheimer's Disease Assesment Scale (ADAS‐Cog) is the most widely used test in clinical trials dealing with Alzheimer's disease (AD). The aim of this study was to investigate the validity and reliability of the Turkish version of ADAS‐Cog. #

Erratum to: Effect of Tramiprosate in Pa

Erratum to: Effect of Tramiprosate in Patients with Mild-to-moderate Alzheimer’s disease: Exploratory Analyses of the MRI sub-group of the Alphase study

✍ S. Gauthier; P. S. Aisen; S. H. Ferris; D. Saumier; Anh Duong; D. Haine; D. Garc 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 106 KB

Effects of memantine on cognition in pat

Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies

✍ Patrizia Mecocci; Anna Bladström; Karina Stender 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

## Abstract ## Objectives The post‐hoc analyses reported here evaluate the specific effects of memantine treatment on ADAS‐cog single‐items or SIB subscales for patients with moderate to severe AD. ## Methods Data from six multicentre, randomised, placebo‐controlled, parallel‐group, double‐blind

A multinational, randomised, 12-week stu

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

✍ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati